- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Lymphoproliferative Disorders in New Zealand
Total 16202 results
-
Kirsten MollerCompletedDelirium | Acute Brain Injury | Acquired Brain InjuriesDenmark
-
Ahmed SawasCompleted
-
Columbia UniversityTerminatedHodgkin Disease | Lymphoma, Non-hodgkinUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Roswell Park Cancer InstituteOrtho Biotech, Inc.Completed
-
University of RochesterCompletedLymphoma, Non-Hodgkin | Hodgkin DiseaseUnited States
-
Gemin XCompleted
-
University of RochesterNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterCelgene; Onyx/AmgenActive, not recruiting
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI)Not yet recruiting
-
PfizerCompletedMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterJuno Therapeutics, Inc., a Bristol-Myers Squibb CompanyActive, not recruitingMultiple MyelomaUnited States
-
Ludwig Institute for Cancer ResearchCancer Research Institute, New York City; MedImmune LLC; Multiple Myeloma Research...TerminatedPhase 1 Study of Tremelimumab, Durvalumab, High-dose Chemotherapy, + Autologous Stem Cell TransplantMultiple MyelomaUnited States
-
Ajai ChariTerminatedMultiple MyelomaUnited States
-
Columbia UniversityCompletedMultiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityCompletedMultiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityCelgeneTerminated
-
NYU Langone HealthCelgeneTerminatedMultiple MyelomaUnited States
-
PfizerCompletedNeoplasms | Lymphoma, Non-HodgkinUnited States
-
Gilead SciencesTerminatedWaldenstrom MacroglobulinemiaUnited States
-
Weill Medical College of Cornell UniversityCelgene CorporationTerminatedWaldenstrom MacroglobulinemiaUnited States
-
Weill Medical College of Cornell UniversityCelgene CorporationTerminatedMultiple MyelomaUnited States
-
NYU Langone HealthCephalonTerminated
-
Memorial Sloan Kettering Cancer CenterUniversity of Alabama at BirminghamRecruitingCentral Nervous System LymphomaUnited States
-
New Mexico Cancer Care AllianceChristus Stehlin Foundation for Cancer ResearchCompletedAdvanced Solid Tumors | LymphomasUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterTufts Medical Center; Lahey ClinicCompleted
-
Weill Medical College of Cornell UniversityCelgeneCompletedMultiple MyelomaUnited States
-
Vivolux ABTheradexTerminated
-
Memorial Sloan Kettering Cancer CenterCompletedMultiple MyelomaUnited States
-
InnoCon MedicalOdense University Hospital; Aarhus University Hospital; Herlev HospitalCompletedUrinary Incontinence | Fecal Incontinence | Urge Incontinence | Urinary Incontinence, Urge | Nocturia | Urinary Frequency More Than Once at Night | Incontinence, Nighttime Urinary | Bowel Disorders FunctionalDenmark
-
Memorial Sloan Kettering Cancer CenterRecruitingFollicular LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedLymphoma | Mantle Cell LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKlineCompletedMantle Cell LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterTrillium Therapeutics Inc.Active, not recruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterJanssen PharmaceuticalsActive, not recruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterCelgene CorporationCompletedMantle Cell Lymphoma | UntreatedUnited States
-
Regeneron PharmaceuticalsNational Cancer Institute (NCI)CompletedLymphoma | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Yale UniversityGenzyme, a Sanofi CompanyCompleted
-
Weill Medical College of Cornell UniversityWithdrawnMantle Cell Lymphoma | Ketogenic DietingUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphomaUnited States
-
Chiron CorporationTerminatedNon-Hodgkin LymphomaUnited States
-
University of RochesterRecruitingMultiple MyelomaUnited States
-
Hackensack Meridian HealthCompletedMultiple MyelomaUnited States
-
Hackensack Meridian HealthJanssen, LPTerminatedMultiple MyelomaUnited States
-
Hackensack Meridian HealthMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Hackensack Meridian HealthGenentech, Inc.TerminatedA Phase II Study of Bevacizumab and Bortezomib in Patients With Relapsed/Refractory Multiple MyelomaMultiple MyelomaUnited States